Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

May 24, 2000

Alpharma USPD Inc. Recalls Albuterol Sulfate Inhalation Solution

Baltimore, MD (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Alpharma USPD Inc. is conducting a recall of Albuterol Sulfate Inhalation Solution, 0.083%, in 3 ml unit dose vials, because the exterior holding carton incorrectly labeled as Ipratropium (vials inside correctly labeled).

The recalled Albuterol Sulfate Inhalation Solution is a prescription used for the prevention and relief of bronchospasm and bears the Lot number of A9H045 EXP 8/01.

FDA stated in its report that 2,340 vials were distributed in New York and Missouri.  The firm estimates none remains on the market.

This Class II recall was initiated by the company, by letter on March 3, 2000.  This is the first public notice issued by the FDA.  The FDA report stated that the company has completed all recall procedures.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-348-0
NDC# 0472-0831-60

Notice of this product warning was sent via email to SafeMail subscribers May 24, 2000.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.